Shanghai Haohai Biological Technology Co (SHSE:688366) Cash per Share : ¥11.60 (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Shanghai Haohai Biological Technology Co Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Shanghai Haohai Biological Technology Co's Cash per Share for the quarter that ended in Sep. 2024 was ¥11.60.

Shanghai Haohai Biological Technology Co Cash per Share Historical Data

The historical data trend for Shanghai Haohai Biological Technology Co's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haohai Biological Technology Co Cash per Share Chart

Shanghai Haohai Biological Technology Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash per Share

Get a 7-Day Free Trial

12.48

11.81

10.43

11.46

11.66

Shanghai Haohai Biological Technology Co Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash per Share	Get a 7-Day Free Trial															11.46	11.54	11.63	11.60	11.66

Shanghai Haohai Biological Technology Co Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Shanghai Haohai Biological Technology Co's Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	2751.082	/	240
	=	11.46

Shanghai Haohai Biological Technology Co's Cash per Share for the quarter that ended in Sep. 2024 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	2692.181	/	232
	=	11.60

Shanghai Haohai Biological Technology Co (SHSE:688366) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Shanghai Haohai Biological Technology Co Cash per Share Related Terms

Thank you for viewing the detailed overview of Shanghai Haohai Biological Technology Co's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Haohai Biological Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Haohai Biological Technology Co Ltd (SHSE:688366) » Definitions » Cash per Share

Comparable Companies

Traded in Other Exchanges

06826:Hong Kong 5HB:Germany

Address

No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN

Website

https://www.3healthcare.com

Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to single operating segment which is the manufacture and sale of biologicals, medical hyaluronate and intraocular lens, research and development of biological engineering and pharmaceutical products and the provision of related services. Its products are categorized into four types comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China which is the key revenue driver, the United States, the United Kingdom, and other countries.

Executives

Tang Min Jie	Directors, senior managers
Du Peng	Core technical personnel
Hou Yong Tai	Director, core technical staff
Jiang Li Xia	Core technical personnel
	Core technical personnel
Liu Lu	Core technical personnel
Ren Cai Xia	senior management
Wang Wen Bin	Senior management, core technical personnel
Wu Jian Ying	Directors, senior managers
Liu Yuan Zhong	Supervisors
Huang Ming	Director
Zhang Jun Dong	Senior management, core technical personnel
You Jie	Director
Tian Min	senior management
Chen Yi Yi	Director

Shanghai Haohai Biological Technology Co Headlines

No Headlines